Institutional Ownership Revolution Medicines, Inc. (RVMD)
This table provides information about the institutional ownership of Revolution Medicines, Inc. (RVMD). We have compiled data on the 266 institutions that hold shares in the stock, with a total of 161 Million shares, which have been reported (via 13F filing form) to have a value of $8.73 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Vanguard Group Inc
Valley Forge, PA |
Nov 13, 2024 Q3 2024 |
14,911,373
shares
|
$842 Million
0.01% of portfolio
|
Q3 2024
Added 3.71%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
13,408,713
shares
|
$757 Million
0.01% of portfolio
|
Q2 2024
Added 8.94%
|
|
|
Wellington Management Group LLP
Boston, MA |
Nov 14, 2024 Q3 2024 |
11,401,394
shares
|
$644 Million
0.09% of portfolio
|
Q3 2024
Reduced 16.54%
|
|
|
Farallon Capital Management LLC
San Francisco, CA |
Nov 14, 2024 Q3 2024 |
11,317,692
shares
|
$639 Million
2.58% of portfolio
|
Q3 2024
Added 15.99%
|
|
|
Baker Bros. Advisors LP
New York, NY |
Nov 14, 2024 Q3 2024 |
7,569,090
shares
|
$427 Million
3.67% of portfolio
|
Q2 2024
Added 0.26%
|
|
|
Nextech Invest Ag
|
Nov 14, 2024 Q3 2024 |
6,296,740
shares
|
$356 Million
46.53% of portfolio
|
Q4 2023
Added 30.11%
|
|
|
Janus Henderson Group PLC
London, X0 |
Nov 14, 2024 Q3 2024 |
6,137,244
shares
|
$347 Million
0.15% of portfolio
|
Q3 2024
Added 32.26%
|
|
|
Paradigm Biocapital Advisors LP
New York, NY |
Nov 14, 2024 Q3 2024 |
5,314,089
shares
|
$300 Million
8.68% of portfolio
|
Q3 2024
Added 1.05%
|
|
|
Price T Rowe Associates Inc
Baltimore, MD |
Nov 14, 2024 Q3 2024 |
5,313,305
shares
|
$300 Million
0.03% of portfolio
|
Q3 2024
Added 1.85%
|
|
|
State Street Corp
Boston, MA |
Nov 14, 2024 Q3 2024 |
5,279,584
shares
|
$298 Million
0.01% of portfolio
|
Q3 2024
Added 4.11%
|
|
|
Bellevue Group Ag
Kuesnacht, V8 |
Nov 14, 2024 Q3 2024 |
4,871,360
shares
|
$275 Million
3.72% of portfolio
|
Q3 2024
Reduced 3.14%
|
|
|
Boxer Capital, LLC
San Diego, CA |
Nov 14, 2024 Q3 2024 |
4,279,464
shares
|
$242 Million
10.29% of portfolio
|
Q4 2023
Reduced 8.64%
|
|
|
Alphabet Inc.
Mountain View, CA |
Nov 07, 2024 Q3 2024 |
4,256,175
shares
|
$240 Million
13.2% of portfolio
|
Q3 2024
Reduced 19.8%
|
|
|
Jpmorgan Chase & CO
New York, NY |
Nov 08, 2024 Q3 2024 |
4,137,920
shares
|
$234 Million
0.02% of portfolio
|
Q3 2024
Added 32.81%
|
|
|
Casdin Capital, LLC
New York, NY |
Nov 14, 2024 Q3 2024 |
4,114,283
shares
|
$232 Million
14.48% of portfolio
|
Q3 2024
Reduced 6.64%
|
|
|
Geode Capital Management, LLC
Boston, MA |
Nov 12, 2024 Q3 2024 |
3,627,025
shares
|
$205 Million
0.01% of portfolio
|
Q3 2024
Added 8.73%
|
|
|
Bvf Inc
San Francisco, CA |
Nov 14, 2024 Q3 2024 |
3,478,612
shares
|
$196 Million
5.01% of portfolio
|
Q3 2024
Reduced 41.84%
|
|
|
Woodline Partners LP
San Francisco, CA |
Nov 14, 2024 Q3 2024 |
3,433,713
shares
|
$194 Million
1.41% of portfolio
|
Q3 2024
Added 4.34%
|
|
|
Deerfield Management Company, L.P. (Series C)
New York, NY |
Nov 14, 2024 Q3 2024 |
2,912,692
shares
|
$164 Million
2.45% of portfolio
|
Q3 2024
Reduced 5.74%
|
|
|
Goldman Sachs Group Inc
New York, NY |
Nov 14, 2024 Q3 2024 |
2,354,602
shares
|
$133 Million
0.02% of portfolio
|
Q3 2024
Added 62.6%
|
|
|
Holocene Advisors, LP
New York, NY |
Nov 14, 2024 Q3 2024 |
2,149,561
shares
|
$121 Million
0.43% of portfolio
|
Q3 2024
Reduced 2.45%
|
|
|
Lord, Abbett & Co. LLC
Jersey City, NJ |
Nov 14, 2024 Q3 2024 |
1,832,021
shares
|
$103 Million
0.27% of portfolio
|
Q3 2024
New holding
|
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
Nov 12, 2024 Q3 2024 |
1,763,117
shares
|
$99.6 Million
0.02% of portfolio
|
Q3 2024
Added 58.88%
|
|
|
Balyasny Asset Management LLC
Chicago, IL |
Nov 14, 2024 Q3 2024 |
1,651,805
shares
|
$93.3 Million
0.13% of portfolio
|
Q3 2024
Reduced 30.11%
|
|
|
Ameriprise Financial Inc
Minneapolis, MN |
Nov 14, 2024 Q3 2024 |
1,485,422
shares
|
$83.9 Million
0.02% of portfolio
|
Q3 2024
Added 0.89%
|